BioSpace News Archive

New data released today by the National Foundation for Infectious Diseases (NFID) revealed that only 52 percent of US adults plan to get vaccinated against influenza (flu) this season.

GrowFL is pleased to announce BioDerm as one of this year’s 50 Florida Companies to Watch (#FLCTW) honorees, a statewide competition that identifies companies expected to see significant growth over the next several years.

Cortexyme, Inc. announced the start of screening in Europe for the GAIN Trial, the company’s ongoing Phase 2/3 clinical study of lead investigational medicine COR388 in subjects with mild to moderate Alzheimer’s disease.

Arena Pharmaceuticals, Inc. presented new data from the Phase 2 OASIS trial for etrasimod, an investigational, once-daily, oral, selective sphingosine 1-phosphate receptor modulator, in development for a range of immune-mediated and inflammatory conditions, including the ongoing ELEVATE UC Phase 3 trial that was initiated this year.

Frank Morese, CEO and CTO of Olea Sensor Networks, will speak at this year’s Telehealth Secrets Conference in Silicon Valley, October 2-4 addressing the benefits of machine learning diagnostic technologies for medical applications.

Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM), a biopharmaceutical company focused on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases, today announced that company management will present an overview of the company at the Cantor 2019 Global Healthcare Conference

Company uses proprietary synthetic biology and genetic engineering technologies to design improved vaccines for serious respiratory infections

The Campus is the first of a series of LifeSci NYC infrastructure and programming investments to cultivate the life sciences and digital health industries in the five boroughs

The CMA has consistently advocated for an enhanced federal role in health care to address national issues, including addressing access issues for seniors, mental health and hard to reach populations.

Steven Garfin MD, Interim Dean, UC San Diego School of Medicine, will join the PrinterPrezz advisory board.